Investor Presentaiton
Investor Presentation
First six months of 2018.
Slide 56
Strengthened insulin volume market share in Region Latin
America
tMU
18
15
12
9
16
3
Latin America modern and new-generation
insulin volume shares
Latin America insulin market by segment
Device penetration
Modern insulin penetration
CAGR volume¹: 11.1%
Penetration
CAGR value¹: 8.9%
60%
70%
60%
Fast-acting
50%
40%
Premix
40%
30%
Long-acting
20%
20%
10%
0%
0%
May
2013
May
2018
May
2013
0
-
Novo Nordisk
Eli Lilly
Sanofi
43%
29%
15%
May
2018
1 CAGR for 5-year period
Note: IMS only covers the following 4 markets in Latin America (retail data): Argentina, Brazil, Colombia, Mexico
Source: IQVIA monthly MAT data May, 2018 volume and value (DKK) figures
MI: Modern insulin; NGI: New-generation insulin
Note: Only top-3 shown
Source: IQVIA monthly MAT data May, 2018 volume figures, numbers do not add up to 100% due to
smaller insulin manufacturers not included
MI: Modern insulin; NGI: New-generation insulin
changing
diabetes
novo nordiskView entire presentation